Renegade.bio provides rapid and cost-effective diagnostic testing for detection of novel infectious diseases.
renegade.bio's investors include SOSV, FinRebel.
renegade.bio is headquartered in Berkeley, United States.
Renegade.bio provides rapid and cost-effective diagnostic testing for detection of novel infectious diseases.
renegade.bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"renegade.bio — Funding & Investors." VCBacked, March 1, 2023, https://www.vcbacked.co/company/renegadebio. Accessed September 30, 2026.
VCBacked. (2023). renegade.bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/renegadebio
{{cite web |title=renegade.bio — Funding & Investors |url=https://www.vcbacked.co/company/renegadebio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated